Life Sciences Virtual Investor Conference: Company Executives Present Live September 16th

Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.

Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, September 16 th with the first live webcast at 9:30 AM ET.

REGISTER NOW AT: https://bit.ly/3zZKJoC

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions.

"We are delighted to host today's innovators from the life science sector," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "Our Virtual Investor Conference platform continues to provide a unique opportunity for these companies to communicate their strategies to a broader investor base."

Agenda and presenting companies:

Time (ET) Presenting Company Ticker(s)
9:30 AM VolitionRx Limited NYSE AMERICAN: VNRX
10:00 AM Avicanna Inc. ( OTCQX: AVCNF | TSX: AVCN)
10:30 AM Alpha Cognition Inc. OTCQB: ACOGF | TSX-V: ACOG
11:00 AM Willow Biosciences Inc. ( OTCQB: CANSF | TSX: WLLW)
11:30 AM Filament Health Corp. ( Pink: FLHLF | NEO: FH)
12:00 PM Novamind Inc. ( OTCQB: NVMDF | CSE: NM)
12:30 PM Salarius Pharmaceuticals, Inc. Nasdaq: SLRX
1:00 PM MedX Health Corp. TSX-V: MDX
1:30 PM Wesana Health Holdings Inc. ( OTCQB: WSNAF | CSE: WESA)
2:00 PM Compass Therapeutics, Inc. OTCQB: CMPX
2:30 PM Else Nutrition Holdings Inc. ( OTCQX: BABYF | TSX-V: BABY)

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com .

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.


CONTACT Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 johnv@lifesciencesinvestorforum.com

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
avicanna news

Avicanna

Leading Biopharmaceutical Research and Development of Commercialized Cannabinoid-Based Products for Global Markets

Leading Biopharmaceutical Research and Development of Commercialized Cannabinoid-Based Products for Global Markets Keep Reading...
Cannabis plant in focus, blurred US flag background.

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday, December 18, President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
Close-up of green cannabis leaves in natural light.

Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions

US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
Gavel on a surface with scattered cannabis leaves, symbolizing legal issues around marijuana.

Hemp THC Recriminalization: A Blow to a Blooming Industry

A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...

Interactive Chart

Latest Press Releases

Related News